Melhores Terapêutica hormonal Terapêutica hormonal em Israel - TOP-10 médicos

A Dra. Pelles Sharon é especialista em hormonioterapia no Sourasky Medical Center (Ichilov), com contribuições notáveis para a pesquisa clínica em tratamentos de câncer.

• Oncologista altamente respeitada com vasta experiência
• Realizou pesquisas sobre as atitudes de pacientes oncológicos em relação a ensaios clínicos
• Oferece uma ampla gama de tratamentos de câncer, incluindo hormonioterapia
• Trabalha em um centro médico de referência em Israel

O Professor Ofer Merimsky lidera a Unidade de Oncologia de Tecidos Moles e Ósseos no Sourasky Medical Center, com décadas de experiência especializada.

• Mais de 25 anos de experiência em terapia hormonal e tratamento de sarcoma
• Investigador sênior no Instituto Weizmann e na Faculdade de Medicina Sackler
• Membro do corpo docente do grupo Sarcoma da ESMO
• Colaborações de pesquisa pioneiras em imunologia tumoral

O Dr. Sarid é especialista em terapia hormonal para vários tipos de câncer, combinando quimioterapia, radioterapia e tratamentos biológicos no Centro Médico Sourasky.

• Oncologista sênior no Sourasky desde 2009
• Formado em uro-oncologia na Universidade de Oxford
• Investigador principal em ensaios clínicos para terapias oncológicas
• Membro da ESMO e da ASCO
• Professor na Universidade de Tel Aviv

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Especialista em terapia hormonal personalizada com foco em perfil genômico – Dr. Raphael lidera ensaios clínicos inovadores no Sourasky Medical Center.

• Professor Sênior com vasta experiência em oncologia médica
• Líder da Iniciativa Nacional de Medicina Genômica de Israel (PSIFAS)
• Investigador principal de múltiplos ensaios clínicos de imunoterapia
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Vencedor de múltiplos prêmios de excelência em ensino da Universidade de Tel-Aviv

Diretor de internamento oncológico no Centro Médico de Tel Aviv – O Dr. Stepfansky lidera programas de terapia hormonal em um dos principais hospitais de Israel.

• Mais de 20 anos de especialização em oncologia e medicina interna
• Pesquisador principal em múltiplos ensaios clínicos para tratamentos oncológicos
• Treinado no prestigiado programa de oncologia do Centro Médico de Tel Aviv
• Especialista tanto no diagnóstico quanto na gestão de terapias hormonais

O Dr. Amir é especialista em terapia hormonal para câncer de mama no Sourasky Medical Center, com prêmios da ESMO e da ISCORT por sua pesquisa.

• Mais de 30 apresentações em reuniões científicas nacionais e internacionais
• Bolsa de Pesquisa Translacional em Câncer de Mama da ESMO (ESMO Breast Cancer Translational Research Fellowship) no Instituto Jules Bordet
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Ganhador de múltiplos prêmios, incluindo o Best Paper of the Year (Melhor Artigo do Ano) da ISCORT

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.